People Background Check
Find People:

Jeffrey Chiang, Age 50Washington, DC

Get Report
Known as:
Jeffrey Chang
Related to:
Kun Ho Song 57 Sharon Sibley 53 Edward Y Chang 92

Jeffrey Chiang Phones & Addresses

Washington, DC

Arlington, VA

Austin, TX

308 Carmel Cir, Ridgecrest, CA 93555 (760) 446-8080

San Diego, CA

Mentions for Jeffrey Chiang

Jeffrey Chiang resumes & CV records

Resumes

Jeffrey Chiang Photo 36

Jeffrey Chiang

Location:
Washington, DC
Industry:
Military
Work:
Washington Nationals Feb 2011 - Feb 2012
Public Relations Us Navy Mar 2010 - Sep 2008
Intelligence Analyst
Education:
Embry - Riddle Aeronautical University 2009
Masters, Management The Johns Hopkins University - Paul H. Nitze School of Advanced International Studies (Sais) 2006 - 2007
Masters, Public Policy The University of Texas at Austin 1992 - 1996
Bachelors, Bachelor of Arts, Political Science, Aerospace Engineering The Johns Hopkins University - Paul H. Nitze School of Advanced International Studies (Sais)
Westlake High School, Austin, Tx
Skills:
National Security, Military, Navy, Security Clearance, Dod, Aviation, Intelligence, Aircraft, Security, Government, Defense
Jeffrey Chiang Photo 37

Investigator At U.s Department Of Labor

Location:
Wakefield, MA
Industry:
Law Enforcement
Work:
U.s. Department of Labor
Senior Investigator U.s. Department of Labor
Investigator at U.s Department of Labor
Education:
Suffolk University 1998 - 2002
Doctor of Jurisprudence, Doctorates, Law Columbia University In the City of New York 1986 - 1990
Bachelors, Bachelor of Arts, Political Science
Jeffrey Chiang Photo 38

Staff Scientist

Location:
10 Center St, Washington Grove, MD 20880
Industry:
Research
Work:
National Institutes of Health
Staff Scientist
Jeffrey Chiang Photo 39

Jeffrey Chiang

Publications & IP owners

Us Patents

Agents And Methods To Elicit Anti-Tumor Immune Response

US Patent:
2020019, Jun 18, 2020
Filed:
Sep 23, 2019
Appl. No.:
16/579583
Inventors:
- New York NY, US
- Rockville MD, US
Jeffrey J. CHIANG - Herndon VA, US
Ihnkyung JANG - Jupiter FL, US
International Classification:
C12N 5/0783
C12N 15/113
G01N 33/50
C12Q 1/25
Abstract:
The invention provides an isolated, purified population of human cells comprising CD8 T cells with reduced Cbl-b activity. The invention provides uses of such cells in methods for inducing or enhancing an anti-tumor immune response in a subject. These methods comprise: (a) providing a cell population, from a subject or from another source, which comprises CD8 T cells, (b) reducing Cbl-b activity in the CD8 T-cells, (c) administering the cells of step (b) to the subject. The invention provides methods for making CD8 T cells that do not require stimulation through a co-receptor in order for the cell to become activated or proliferated in response to contact via its T cell receptor. Such methods are based upon reducing function of Cbl-b. The invention also provides methods for identifying agents which affect Cbl-b expression or activity.

Agents And Methods To Elicit Anti-Tumor Immune Response

US Patent:
2018031, Nov 1, 2018
Filed:
Mar 19, 2018
Appl. No.:
15/925148
Inventors:
- New York NY, US
- Bethesda MD, US
Jeffrey J. CHIANG - Herndon VA, US
Ihnkyung JANG - Jupiter FL, US
International Classification:
C12N 5/0783
Abstract:
The invention provides an isolated, purified population of human cells comprising CD8 T cells with reduced Cbl-b activity. The invention provides uses of such cells in methods for inducing or enhancing an anti-tumor immune response in a subject. These methods comprise: (a) providing a cell population, from a subject or from another source, which comprises CD8 T cells, (b) reducing Cbl-b activity in the CD8 T-cells, (c) administering the cells of step (b) to the subject. The invention provides methods for making CD8 T cells that do not require stimulation through a co-receptor in order for the cell to become activated or proliferated in response to contact via its T cell receptor. Such methods are based upon reducing function of Cbl-b. The invention also provides methods for identifying agents which affect Cbl-b expression or activity.

Agents And Methods To Elicit Anti-Tumor Immune Response

US Patent:
2016031, Oct 27, 2016
Filed:
Apr 1, 2016
Appl. No.:
15/089016
Inventors:
- New York NY, US
- Rockville MD, US
Jeffrey J. CHIANG - Herndon VA, US
Ihnkyung JANG - Jupiter FL, US
International Classification:
C12N 5/0783
Abstract:
The invention provides an isolated, purified population of human cells comprising CD8 T cells with reduced Cbl-b activity. The invention provides uses of such cells in methods for inducing or enhancing an anti-tumor immune response in a subject. These methods comprise: (a) providing a cell population, from a subject or from another source, which comprises CD8 T cells, (b) reducing Cbl-b activity in the CD8 T-cells, (c) administering the cells of step (b) to the subject. The invention provides methods for making CD8 T cells that do not require stimulation through a co-receptor in order for the cell to become activated or proliferated in response to contact via its T cell receptor. Such methods are based upon reducing function of Cbl-b. The invention also provides methods for identifying agents which affect Cbl-b expression or activity.

Possible Relatives

Dawn Chiang  Daniel Chiang  Diana A Chiang  Donna W Chiang  Eileen L Chiang  Fen Chiang  Gloria Chiang  Jeffrey M Standley  Jeffrey A Johnston  Jeffrey M Stanek 

NOTICE: You may not use PeopleBackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. PeopleBackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.